3 Questions: Leveraging carbon uptake to lower concrete’s carbon footprint
MIT CSHub Deputy Director Hessam AzariJafari is conducting vital research to investigate the impacts of concrete's carbonation across its life cycle.
3 Questions: The Iraq invasion, 20 years later
MIT scholars discuss the history behind the war, lessons learned on state-building, and Iraq’s current political outlook.
3 Questions: How automation and good jobs can co-exist
Work of the Future Initiative co-directors Julie Shah and Ben Armstrong describe their vision of “positive-sum automation.”
3 Questions: John Dozier on Dialogues Across Difference
A new campus series intends to inspire conversation about building community across the Institute.
3 Questions: Mriganka Sur on the research origins of the first approved drug to treat Rett syndrome
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
3 Questions: Antje Danielson on energy education and its role in climate action
The MIT Energy Initiative’s director of education shares new initiatives aimed at preparing students to take an active role in solving the climate crisis.
3Q: What we learned from the asteroid-smashing DART mission
Saverio Cambioni discusses new results revealing the redirected asteroid Dimorphos to be a dust-trailing rubble-pile.
3 Questions: Daniel Auguste on why “successful entrepreneurs don’t fall from the sky”
The MLK Visiting Professor studies the ways innovators are influenced by their communities.
Q&A: Tod Machover on “Overstory Overture,” his new operatic work
MIT composer’s piece premieres at Lincoln Center on March 7, with superstar Joyce DiDonato in a leading — and surprising — role.
3 Questions: The power of music in advancing social justice
Frederick Harris Jr., MIT senior lecturer and creator of the It Must Be Now! initiative, reflects on music’s historic role in addressing racial issues.
3 Questions: Leo Anthony Celi on ChatGPT and medicine
The chatbot’s success on the medical licensing exam shows that the test — and medical education — are flawed, Celi says.
3 Questions: Cullen Buie on a new era for cell therapies
The associate professor of MechE reflects on how his company, Kytopen, has grown and shifted focus in developing safer immunotherapies.
3 Questions: Sulafa Zidani on tech, culture, and a critical transnational perspective
The media scholar speaks on her research and her experience at MIT.
3 Questions: What to expect from respiratory illnesses, including Covid-19, this winter
MIT Medical Director Cecilia Stuopis says that while this is a time to be more vigilant, people should not panic.
Q&A: A fresh look at data science
MIT Visiting Scholar Alfred Spector discusses the power of data science and visualization, as well as his new textbook on the subject.